These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1292247)

  • 1. Effect of captopril on heavy proteinuria in patients with various glomerular diseases.
    Han DS; Ha SK; Choi KH; Lee HY
    Yonsei Med J; 1992 Sep; 33(3):232-9. PubMed ID: 1292247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis.
    Praga M; Paz Artal E; Hernández E; Segura J; Moreno MA; Morales JM; Rodicio JL
    Nephrol Dial Transplant; 1997 Dec; 12(12):2576-9. PubMed ID: 9430854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
    Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
    Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproteinuric effect of angiotensin-converting-enzyme inhibitors in patients with primary glomerular disease and normal renal function.
    Fabbri A; Cocchi R; Degli Esposti E; Lucatello A; Sturani A; Tampieri G; Fusaroli M
    Nephrol Dial Transplant; 1990; 5 Suppl 1():81-3. PubMed ID: 2129469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
    Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of captopril on proteinuria in glomerular diseases].
    Yamaguchi Y; Saito T; Obara K; Ootaka T; Akiu N; Sato H; Kinoshita Y; Seino J; Tsunoda K; Yasujima M
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1009-16. PubMed ID: 2263022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy.
    Huissoon AP; Meehan S; Keogh JA
    Ir J Med Sci; 1991 Oct; 160(10):319-21. PubMed ID: 1810899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria.
    Ruilope LM; Miranda B; Oliet A; Millet VG; Rodicio JL; Romero JC; Raij L
    J Hypertens Suppl; 1988 Dec; 6(4):S467-9. PubMed ID: 3071587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproteinuric effect of captopril in primary glomerular disease.
    Lagrue G; Robeva R; Laurent J
    Nephron; 1987; 46(1):99-100. PubMed ID: 3299120
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies].
    Boratyńska M; Mazanowska O; Szewczyk Z; Czyz W
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1090-2. PubMed ID: 1305732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function.
    Palla R; Panichi V; Finato V; Parrini M; Andreini B; Bianchi AM; Giovannini L; Migliori M; Bertelli AA
    Int J Clin Pharmacol Res; 1994; 14(1):35-43. PubMed ID: 7927959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
    Kim MJ; Song JH; Suh JH; Lee SW; Kim GA
    Yonsei Med J; 2003 Jun; 44(3):463-72. PubMed ID: 12833584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
    Chen YM; Lin SL; Chiang WC; Wu KD; Tsai TJ
    Kidney Int; 2006 Apr; 69(8):1410-5. PubMed ID: 16541021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J; Banihashemi MA; Ghezlou M; Afshariani R; Salari S; Moini M; Sagheb MM
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
    Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R; Salinas I; Teixidó J; Lucas A; Felip A; Sanmarti A
    J Hum Hypertens; 1990 Dec; 4(6):671-5. PubMed ID: 2096209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.